查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1877453

奈米生物技術市場：依產品類型、治療方法、應用、最終用戶、國家及地區分類－全球產業分析、市場規模、市場佔有率及2025-2032年預測

Nano-biotechnology Market, By Product Type, By Therapeutics, By Application, By End-User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 375 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年奈米生物技術市場規模價值為 1,712.3489 億美元，從 2025 年到 2032 年以 9.5% 的複合年成長率成長。

奈米生物技術將奈米技術與生物技術結合，在分子和細胞層面開發用於醫療保健、農業和環境應用的材料和裝置。標靶藥物傳遞和診斷工具的進步加速了相關研究，目前全球已有超過350種奈米藥物產品正在進行臨床試驗。然而，高昂的製造成本和監管障礙限制了其大規模商業化。對精準醫療、生物影像解決方案和永續農業實踐日益成長的需求，為新創公司和成熟公司提供了創新機會。此外，大學與生技公司之間的合作，例如麻省理工學院與NanoTech公司的合作，正在拓展研發能力和產品線，增強了該領域的潛力，使其能夠克服成本和政策方面的挑戰。

奈米生物技術市場—市場動態

精準創新與新興應用推動奈米生物技術市場發展

奈米生物技術透過將奈米技術與生物系統結合，創造出創新解決方案，正在徹底改變醫療保健、農業和環境領域。在醫療領域，美國國家奈米技術計畫重點關注奈米醫學的進步，包括標靶藥物遞送系統和診斷工具，這些工具能夠提高治療效果並促進疾病的早期檢測。例如，美國食品藥物管理局（FDA）已批准多種奈米技術療法，例如用於癌症治療的脂質體阿黴素製劑Doxil。在農業領域，奈米技術促進了智慧肥料和農藥的開發，從而提高作物產量並減少對環境的影響。美國農業部一直支持奈米農業產品的研究，這些產品能夠增強營養輸送和提高作物的抗蟲害能力。

奈米生物技術市場細分分析：

全球奈米生物技術市場按產品類型、治療方法、應用、最終用戶和地區進行細分。

依產品類型，奈米材料市場可分為五大類：奈米材料、奈米裝置、奈米載體、試劑及耗材以及儀器及工具。奈米載體因其在標靶藥物遞送中的關鍵作用而佔據市場主導地位，其次是用於診斷和治療的奈米材料。奈米元件則位列第三，為精準應用提供支持，而儀器及工具和試劑及耗材在研發領域則佔據中等重要性。

根據治療領域，奈米生物技術市場分為五大類：癌症、牙科、心臟、骨科及其他。由於標靶藥物傳遞和診斷的廣泛研究，癌症治療在奈米生物技術領域佔據主導地位；其次是針對心血管疾病的心臟應用。骨科和牙科應用受到的關注度中等，而其他治療領域，包括神經系統疾病和傳染病，雖然正在興起，但優先順序較低。

奈米生物技術市場—地理洞察

奈米生物技術領域正經歷顯著的全球擴張，這主要得益於策略合作和收購。 2025年，奧爾巴尼大學奈米材料與奈米電子學先進技術中心（CATN2）獲得了1000萬美元的州政府撥款，用於推進半導體、微系統和生物醫學技術的研究。這筆資金支持與包括GlobalFoundries和IBM在內的150多家公司的合作，預計將帶來16億美元的經濟效益，並創造超過1,750個就業機會。此外，專注於脂質奈米顆粒技術的加拿大公司Precision NanoSystems被Cytiva收購，增強了其在mRNA疫苗開發方面的能力。這些發展凸顯了該領域蓬勃發展的態勢，而這種發展是由產學研合作和策略性企業整合所驅動的。

奈米生物技術市場—國家/地區洞察

美國在奈米生物技術領域仍維持全球領先地位，其策略性併購與合作是其顯著特徵。 2025年3月，阿斯特捷利康斥資高達10億美元收購比利時生物技術公司EsoBiotec，旨在提升其細胞療法能力，尤其是在癌症和自體免疫疾病領域。在此次收購之前，美國還進行了其他重大投資，包括以高達12億美元收購Gracell Biotechnologies，以及在馬裡蘭州投資3億美元用於細胞療法研發。此外，美國國家奈米技術計劃持續資助跨學科研究，促進奈米醫學和診斷領域的創新。這些進展凸顯了該領域的蓬勃發展，而這種發展是由產學研合作和策略性企業整合所驅動的。

奈米生物技術市場—競爭格局：

奈米生物技術領域的競爭格局以策略性併購和合作為特徵，這些措施旨在提升創新能力和市場地位。 2025年，阿斯特捷利康斥資高達10億美元收購了EsoBiotec，以增強其細胞療法能力，尤其是在癌症和自體免疫疾病領域。同樣，賽諾菲宣布計劃以11.5億美元收購英國生技公司Vicebio，旨在增強其呼吸道疫苗產品線。在美國，奧爾巴尼大學奈米材料與奈米電子先進技術中心（CATN2）獲得了1000萬美元的州政府撥款，以加強其在半導體和微電子研究領域的作用，並促進與GlobalFoundries和IBM等公司的公私合作。這些發展凸顯了奈米生物技術領域的蓬勃發展，而這種發展是由策略性的企業行動和機構支持共同驅動的。

目錄

第1章：奈米生物技術市場概覽

  • 研究範圍
  • 市場估算年份

第2章：執行概要

  • 市集
    • 奈米生物技術市場按產品類型分類的概覽
    • 奈米生物技術市場概況（按治療領域分類）
    • 奈米生物技術市場按應用領域分類的概覽
    • 奈米生物技術市場按最終用戶分類的概況
    • 各國奈米生物技術市場概況
    • 奈米生物技術市場概覽（按地區分類）
  • 競爭洞察

第3章：奈米生物技術主要市場趨勢

  • 奈米生物技術市場促進因素
    • 市場促進因素的影響分析
  • 奈米生物技術市場限制因素
    • 市場限制因素的影響分析
  • 奈米生物技術市場機遇
  • 奈米生物技術市場未來趨勢

第4章：奈米生物技術產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景分析
  • 規範架構分析

第5章：奈米生物技術市場：地緣政治緊張局勢升級的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：奈米生物技術市場概況

  • 奈米生物技術市場佔有率分析，2024年
  • 主要製造商細分數據
    • 知名球員分析
    • 新興參與者分析

第7章：奈米生物技術市場－依產品類型分類

  • 概述
    • 按產品類型分類的細分市場佔有率分析
    • 奈米材料
      • 奈米管
      • 奈米顆粒
    • 奈米裝置
      • 奈米晶片
      • 生物感測器
    • 奈米載體
      • 脂質體
      • 樹狀聚合物
    • 試劑和耗材
    • 儀器和工具

第8章：奈米生物技術市場－依治療領域分類

  • 概述
    • 按治療領域分類的細分市場佔有率分析
    • 癌症
    • 牙科
    • 心臟
    • 骨科
    • 其他

第9章：奈米生物技術市場－按應用領域分類

  • 概述
    • 按應用領域分類的細分市場佔有率分析
    • 藥物遞送
    • 診斷與影像
    • 再生醫學
    • 組織工程
    • 疫苗研發

第10章：奈米生物技術市場－以最終用戶分類

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 製藥和生物技術公司
    • 研究機構
    • 醫院和診斷實驗室
    • 學術機構
    • 其他

第11章：奈米生物技術市場－依地域分類

  • 介紹
    • 按地域分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美奈米生物技術主要製造商
    • 北美市場規模及預測（按國家/地區分類）
    • 北美市場規模及預測（依產品類型分類）
    • 北美市場規模及預測（依治療領域分類）
    • 北美市場規模及預測（按應用分類）
    • 北美市場規模及預測（依最終用戶分類）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲奈米生物技術主要製造商
    • 歐洲市場規模及預測（按國家/地區分類）
    • 歐洲市場規模及預測（依產品類型分類）
    • 歐洲市場規模及預測（依治療領域分類）
    • 歐洲市場規模及預測（按應用領域分類）
    • 歐洲市場規模及預測（依最終用戶分類）
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 歐洲其他地區
  • 亞太地區
    • 概述
    • 亞太地區奈米生物技術主要製造商
    • 亞太市場規模及預測（依國家/地區分類）
    • 亞太市場規模及預測（依產品類型分類）
    • 亞太地區市場規模及預測（依治療領域分類）
    • 亞太市場規模及預測（按應用分類）
    • 亞太市場規模及預測（依最終用戶分類）
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 亞太其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲奈米生物技術主要製造商
    • 拉丁美洲市場規模及預測（按國家/地區分類）
    • 拉丁美洲市場規模及預測（依產品類型分類）
    • 拉丁美洲市場規模及預測（依治療領域分類）
    • 拉丁美洲市場規模及預測（按應用分類）
    • 拉丁美洲市場規模及預測（按最終用戶分類）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲（MEA）
    • 概述
    • 中東和非洲奈米生物技術主要製造商
    • MEA市場規模及預測（依國家/地區分類）
    • MEA市場規模及預測（依產品類型分類）
    • MEA市場規模及預測（依治療領域分類）
    • MEA市場規模及預測（依應用分類）
    • MEA市場規模及預測（依最終用戶分類）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 中東和非洲其他地區

第12章：主要供應商分析－奈米生物技術產業

  • 競爭格局分析
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司簡介
    • Affymetrix, Inc.
    • Agilent Technologies, Inc.
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories, Inc.
    • Bruker Corporation
    • Carl Zeiss AG
    • Danaher Corporation
    • GE Healthcare
    • Hitachi High-Technologies Corporation
    • Illumina, Inc.
    • JEOL Ltd.
    • Merck KGaA
    • Nanobiotix
    • Nikon Corporation
    • Oxford Instruments plc
    • PerkinElmer, Inc.
    • Qiagen NV
    • Shimadzu Corporation
    • Tecan Group Ltd.
    • Thermo Fisher Scientific, Inc.
    • Others

第13章：360度AnalystView

第14章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV5708

Nano-biotechnology Market size was valued at US$ 171,234.89 Million in 2024, expanding at a CAGR of 9.5% from 2025 to 2032.

Nano-biotechnology integrates nanotechnology with biotechnology to develop materials and devices at a molecular and cellular level for healthcare, agriculture, and environmental applications. Advancements in targeted drug delivery and diagnostic tools have accelerated research, with over 350 nanomedicine products currently in clinical trials globally. However, high manufacturing costs and regulatory hurdles limit large-scale commercialization. Growing demand for precision medicine, bio-imaging solutions, and sustainable agricultural practices presents opportunities for startups and established companies to innovate. Additionally, collaborations between universities and biotech firms, such as MIT partnering with NanoTech Inc., are expanding R&D capabilities and product pipelines, reinforcing the sector's potential despite cost and policy challenges.

Nano-biotechnology Market- Market Dynamics

Precision Innovations and Emerging Applications Propel Nano-biotechnology Market

Nano-biotechnology is revolutionizing healthcare, agriculture, and environmental sectors by merging nanotechnology with biological systems to create innovative solutions. In the medical field, the U.S. National Nanotechnology Initiative highlights advancements in nanomedicine, including targeted drug delivery systems and diagnostic tools that enhance treatment efficacy and early disease detection. For instance, the FDA has approved several nano-enabled therapeutics, such as Doxil, a liposomal formulation of doxorubicin used in cancer therapy. In agriculture, nanotechnology facilitates the development of smart fertilizers and pesticides, improving crop yield and reducing environmental impact. The U.S. Department of Agriculture has supported research into nano-based agricultural products that enhance nutrient delivery and pest resistance.

Nano-biotechnology Market- Segmentation Analysis:

The Global Nano-biotechnology Market is segmented on the basis of Product Type, Therapeutics, Application, End-User, and Region.

The market is divided into five categories based on product type: Nanomaterials, Nanodevices, Nanocarriers, Reagents & Consumables, and Instruments & Tools. Nanocarriers lead the market due to their critical role in targeted drug delivery, followed by nanomaterials for diagnostics and therapeutics. Nanodevices rank next, supporting precision applications, while instruments & tools and reagents & consumables hold moderate priority in research and development.

The market is divided into five categories based on Therapeutics: Cancer, Dental, Cardiac, Orthopedic, and Others. Cancer therapeutics dominate the nano-biotechnology segment owing to extensive research in targeted drug delivery and diagnostics, followed by cardiac applications addressing cardiovascular disorders. Orthopedic and dental applications hold a moderate focus, while other therapeutic areas, including neurological and infectious diseases, have emerging but lower priority.

Nano-biotechnology Market- Geographical Insights

The nano-biotechnology sector is experiencing significant global expansion, fueled by strategic collaborations and acquisitions. In 2025, the University at Albany's Center for Advanced Technology in Nanomaterials and Nanoelectronics (CATN2) secured a $10 million state grant to advance research in semiconductors, microsystems, and biomedical technologies. This funding supports partnerships with over 150 companies, including GlobalFoundries and IBM, contributing to an estimated economic impact of $1.6 billion and the creation of more than 1,750 jobs. Additionally, Precision NanoSystems, a Canadian firm specializing in lipid nanoparticle technologies, was acquired by Cytiva, enhancing capabilities in mRNA vaccine development. These developments underscore the sector's dynamic growth, driven by academic-industry partnerships and strategic corporate consolidations.

Nano-biotechnology Market- Country Insights

The United States remains a global leader in nano-biotechnology, marked by strategic mergers and collaborations. In March 2025, AstraZeneca acquired Belgian biotech firm EsoBiotec for up to $1 billion, aiming to enhance its cell therapy capabilities, particularly in cancer and autoimmune diseases. This acquisition follows other significant investments, including the purchase of Gracell Biotechnologies for up to $1.2 billion and a $300 million investment in Maryland for cell therapy development. Additionally, the U.S. National Nanotechnology Initiative continues to fund interdisciplinary research, fostering innovation in nanomedicine and diagnostics. These developments underscore the sector's dynamic growth, driven by academic-industry partnerships and strategic corporate consolidations.

Nano-biotechnology Market- Competitive Landscape:

The competitive landscape of nano-biotechnology is marked by strategic mergers, acquisitions, and collaborations that enhance innovation and market positioning. In 2025, AstraZeneca acquired EsoBiotec for up to $1 billion to advance its cell therapy capabilities, particularly in cancer and autoimmune diseases. Similarly, Sanofi announced plans to acquire UK-based biotech firm Vicebio for $1.15 billion, aiming to enhance its respiratory vaccine offerings. In the U.S., the University at Albany's Center for Advanced Technology in Nanomaterials and Nanoelectronics (CATN2) secured a $10 million state grant to bolster its role in semiconductor and microelectronics research, fostering public-private partnerships with companies like GlobalFoundries and IBM. These developments underscore the dynamic nature of the nano-biotechnology sector, driven by strategic corporate actions and institutional support.

Recent Developments:

In September 2024, scientists at the National Institute of Agricultural Botany (NIAB) developed a diagnostic kit to detect antibiotics in animal food, alongside a nano-mineral biocapsule for targeted delivery of nutrients, drugs, and bioactive molecules, enhancing food safety and precision nutrition.

In September 2024, NanoSyrinx secured £10 million (USD 12.2 million) funding to develop its innovative nano syringe delivery platform, enabling precise transport of peptide and protein payloads directly into the cytosol of targeted cells for advanced therapeutic applications.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NANO-BIOTECHNOLOGY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Affymetrix, Inc.
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • Carl Zeiss AG
  • Danaher Corporation
  • GE Healthcare
  • Hitachi High-Technologies Corporation
  • Illumina, Inc.
  • JEOL Ltd.
  • Merck KGaA
  • Nanobiotix
  • Nikon Corporation
  • Oxford Instruments plc
  • PerkinElmer, Inc.
  • Qiagen N.V.
  • Shimadzu Corporation
  • Tecan Group Ltd.
  • Thermo Fisher Scientific, Inc.
  • Others

GLOBAL NANO-BIOTECHNOLOGY MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Nanomaterials
  • Nanotubes
  • Nanoparticles
  • Nanodevices
  • Nanochips
  • Biosensors
  • Nanocarriers
  • Liposomes
  • Dendrimers
  • Reagents & Consumables
  • Instruments & Tools

GLOBAL NANO-BIOTECHNOLOGY MARKET, BY THERAPEUTICS- MARKET ANALYSIS, 2019 - 2032

  • Cancer
  • Dental
  • Cardiac
  • Orthopedic
  • Others

GLOBAL NANO-BIOTECHNOLOGY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Drug Delivery
  • Diagnostics & Imaging
  • Regenerative Medicine
  • Tissue Engineering
  • Vaccine Development

GLOBAL NANO-BIOTECHNOLOGY MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical & Biotechnology Companies
  • Research Institutes
  • Hospitals & Diagnostic Labs
  • Academic Institutions
  • Others

GLOBAL NANO-BIOTECHNOLOGY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Nano-biotechnology Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Nano-biotechnology Market Snippet by Product Type
    • 2.1.2. Nano-biotechnology Market Snippet by Therapeutics
    • 2.1.3. Nano-biotechnology Market Snippet by Application
    • 2.1.4. Nano-biotechnology Market Snippet by End-User
    • 2.1.5. Nano-biotechnology Market Snippet by Country
    • 2.1.6. Nano-biotechnology Market Snippet by Region
  • 2.2. Competitive Insights

3. Nano-biotechnology Key Market Trends

  • 3.1. Nano-biotechnology Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Nano-biotechnology Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Nano-biotechnology Market Opportunities
  • 3.4. Nano-biotechnology Market Future Trends

4. Nano-biotechnology Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Nano-biotechnology Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Nano-biotechnology Market Landscape

  • 6.1. Nano-biotechnology Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Nano-biotechnology Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. Nanomaterials
      • 7.1.2.1. Nanotubes
      • 7.1.2.2. Nanoparticles
    • 7.1.3. Nanodevices
      • 7.1.3.1. Nanochips
      • 7.1.3.2. Biosensors
    • 7.1.4. Nanocarriers
      • 7.1.4.1. Liposomes
      • 7.1.4.2. Dendrimers
    • 7.1.5. Reagents & Consumables
    • 7.1.6. Instruments & Tools

8. Nano-biotechnology Market - By Therapeutics

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Therapeutics, 2024 & 2032 (%)
    • 8.1.2. Cancer
    • 8.1.3. Dental
    • 8.1.4. Cardiac
    • 8.1.5. Orthopedic
    • 8.1.6. Others

9. Nano-biotechnology Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 9.1.2. Drug Delivery
    • 9.1.3. Diagnostics & Imaging
    • 9.1.4. Regenerative Medicine
    • 9.1.5. Tissue Engineering
    • 9.1.6. Vaccine Development

10. Nano-biotechnology Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2024 & 2032 (%)
    • 10.1.2. Pharmaceutical & Biotechnology Companies
    • 10.1.3. Research Institutes
    • 10.1.4. Hospitals & Diagnostic Labs
    • 10.1.5. Academic Institutions
    • 10.1.6. Others

11. Nano-biotechnology Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Nano-biotechnology Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Nano-biotechnology Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Nano-biotechnology Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Nano-biotechnology Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Nano-biotechnology Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Nano-biotechnology Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Affymetrix, Inc.
    • 12.2.2. Agilent Technologies, Inc.
    • 12.2.3. Becton, Dickinson and Company
    • 12.2.4. Bio-Rad Laboratories, Inc.
    • 12.2.5. Bruker Corporation
    • 12.2.6. Carl Zeiss AG
    • 12.2.7. Danaher Corporation
    • 12.2.8. GE Healthcare
    • 12.2.9. Hitachi High-Technologies Corporation
    • 12.2.10. Illumina, Inc.
    • 12.2.11. JEOL Ltd.
    • 12.2.12. Merck KGaA
    • 12.2.13. Nanobiotix
    • 12.2.14. Nikon Corporation
    • 12.2.15. Oxford Instruments plc
    • 12.2.16. PerkinElmer, Inc.
    • 12.2.17. Qiagen N.V.
    • 12.2.18. Shimadzu Corporation
    • 12.2.19. Tecan Group Ltd.
    • 12.2.20. Thermo Fisher Scientific, Inc.
    • 12.2.21. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us